Company / Tangible Book Value per Share
Supernus Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$16.81
FY2025
5-year range
$13.21 / $16.81
FY2021-FY2025
Trend
+0.1%
vs FY2024
Sector context
#30 of 209
Health Care
What the data says
Supernus Pharmaceuticals, Inc.'s tangible book value per share of $16.81 is higher than 86% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has increased for 9 consecutive years, from $0.83 in FY2016 to $16.81 in FY2025.
Based on SEC 10-K filings.
16.81 in FY2025 with a 5-year CAGR of +5.8%. Top quartile in the Health Care sector.
Improved from $14.49 to $16.81 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +5.2%
- 5-Year CAGR
- +5.8%
- 10-Year CAGR
- -
Sector benchmark
-82.0% below sector average
Key checks
Key Insights
- Supernus Pharmaceuticals, Inc.'s tangible book value per share has grown for 9 consecutive years.
- In FY2025, tangible book value per share increased 0.1% year-over-year.
- Ranks #30 out of 209 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.81 | +0.1% |
| FY2024 | $16.79 | +15.8% |
| FY2023 | $14.49 | +0.3% |
| FY2022 | $14.44 | +9.3% |
| FY2021 | $13.21 | +4.0% |
| FY2020 | $12.70 | +11.5% |
| FY2019 | $11.38 | +204.6% |
| FY2018 | $3.74 | +112.2% |
| FY2017 | $1.76 | +112.1% |
| FY2016 | $0.83 | -59.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026